CLINICAL_TRIALS
trial_result
· 2016-10-12
Clinical Trial Update: The Effect of Obesity in Dexmedetomidine Metabolic Clearance [Phase 4]
Summary
This Phase 4 clinical trial update examines the impact of obesity on the metabolic clearance of dexmedetomidine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Obesity | Phase 4 | Status: UNKNOWN